COVACTA trial raises questions about tocilizumab's benefit in COVID-19
Lancet Rheumatol
.
2020 Oct;2(10):e592.
doi: 10.1016/S2665-9913(20)30313-1.
Epub 2020 Sep 9.
Author
Bryant Furlow
PMID:
32929415
PMCID:
PMC7480990
DOI:
10.1016/S2665-9913(20)30313-1
No abstract available